Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Significant Drop in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBTGet Free Report) was the recipient of a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 21,391 shares, a drop of 32.6% from the December 31st total of 31,742 shares. Based on an average trading volume of 20,233 shares, the short-interest ratio is presently 1.1 days. Currently, 0.0% of the company’s shares are short sold. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 20,233 shares, the short-interest ratio is presently 1.1 days.

Zhengye Biotechnology Trading Up 4.0%

Shares of ZYBT opened at $0.98 on Friday. The company’s fifty day simple moving average is $1.55 and its 200-day simple moving average is $3.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.49 and a quick ratio of 1.10. Zhengye Biotechnology has a twelve month low of $0.90 and a twelve month high of $14.30.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Zhengye Biotechnology in a research note on Friday, January 9th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

View Our Latest Research Report on ZYBT

Institutional Trading of Zhengye Biotechnology

Several institutional investors have recently added to or reduced their stakes in the company. Millennium Management LLC purchased a new position in Zhengye Biotechnology in the 3rd quarter worth about $38,000. Citadel Advisors LLC bought a new position in Zhengye Biotechnology in the 3rd quarter worth about $31,000. WINTON GROUP Ltd bought a new position in Zhengye Biotechnology in the 3rd quarter worth about $56,000. Jane Street Group LLC purchased a new position in shares of Zhengye Biotechnology during the second quarter worth approximately $1,158,000. Finally, Invesco Ltd. bought a new stake in shares of Zhengye Biotechnology during the second quarter valued at approximately $220,000.

Zhengye Biotechnology Company Profile

(Get Free Report)

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Featured Stories

Receive News & Ratings for Zhengye Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhengye Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.